TABLE 2.
Characteristics of TRT‐naive and TRT‐treated adult KS patients and age‐matched 46,XY control group
| TRT‐naive | TRT‐treated | Control group | |
|---|---|---|---|
| KS patients ≥ 18 years | n = 70 | n = 54 | n = 50 |
| Age (years) ± SD range | 35 ± 11 (18–63) | 35 ± 11 (19–61) | 43 ± 12 (21–64) |
| FSH (mIU/ml) ± SD | 27.9 ± 13.2 | 17.5 ± 14.4 | 4.3 ± 1.8 |
| LH (mIU/ml) ± SD | 14.5 ± 6.1 | 10.5 ± 8.7 | 3.2 ± 1.3 |
| T (nmol/l) ± SD | 10.5 ± 8.4 | 10.4 ± 8.4 | 5.9 ± 1.6 |
| E2 (pg/ml) ± SD | 33.0 ± 13.4 | 30.7 ± 16.7 | 29.3 ± 12.6 |
| SHBG (nmol/l) ± SD | 45.4 ± 24.8 | 37.8 ± 23.3 | 34.2 ± 14.1 |
Abbreviations: E2, estradiol; FSH, follicle‐stimulating hormone; LH, luteinizing hormone; SD, standard deviation; SHBG, sex hormone‐binding globulin; T, total testosterone; TRT, testosterone replacement therapy.